Kan. Admin. Regs. § 40-4-42e - Minimum qualifications for external review organizations
(a) To be approved
under K.A.R. 40-4-42e and
L.
1999 , Ch. 162 , Secs. 6
through 9, and amendments thereto, to conduct external reviews, an external
review organization shall have and maintain written policies and procedures
that govern all aspects of both the standard external review process and the
expedited external review process set forth in K.A.R. 40-4-42c and K.A.R.
40-4-42d and that include at minimum:
(1) A
quality assurance mechanism in place that meets the following criteria:
(A) Ensures that external reviews are
conducted within the specified time frames and required notices are provided in
a timely manner;
(B) ensures the
selection of qualified and impartial clinical peer reviewers to conduct
external reviews on behalf of the external review organization and suitable
matching of reviewers to specific cases;
(C) ensures the confidentiality of medical
and treatment records and clinical review criteria; and
(2) a toll-free
telephone service to receive, on a 24 hours per day, seven days per week basis,
information related to external review that is capable of accepting, recording,
or providing appropriate instructions to incoming telephone callers during
other than normal business hours; and
(3) an agreement to maintain and provide to
the commissioner the information set out in K.A.R. 40-4-42g .
(b) All clinical peer reviewers
assigned by an external review organization to conduct external reviews shall
be physicians or other appropriate health care providers who meet the following
minimum qualifications:
(1) Are qualified and
credentialed in the treatment of the insured's medical condition that is the
subject of the external review;
(2) are knowledgeable about the recommended
health care service or treatment through actual or recent clinical experience
that may be based on the following:
(A) The
actual treatment of patients with the same or similar medical condition as that
of the insured; and
(B) the period
of time that has elapsed between the clinical experience and the present;
(3) hold a
nonrestricted license in a state of the United States and, for physicians, a
current certification by a recognized American medical specialty board in the
area or areas appropriate to the subject of the external review; and
(4) have no history of disciplinary actions
or sanctions, including loss of staff privileges or any participation
restriction that has been taken or is pending by any hospital, governmental
agency or unit, or regulatory body, that raises a substantial question as to
the clinical peer reviewer's physical, mental, or professional competence, or
moral character.
(c) In
addition to the requirements set forth in subsection (a) of this regulation, an
external review organization shall not own or control, be a subsidiary of, or
in any way be owned or controlled by, or exercise control, with any of the
following:
(1) An insurance plan;
(2) a national, state, or local trade
association of health insurance plans; or
(3) a national, state, or local trade
association of health care providers.
(d) In addition to the requirements set forth
in subsections (a), (b), and (c) of this regulation, to be approved pursuant to
L.
1999 , Ch. 162 , Sec. 8,
and amendments thereto, to conduct an external review of a specified case,
neither the external review organization selected to conduct the external
review nor any clinical peer review assigned by the external organization to
conduct the external review may have a material professional, familial, or
financial conflict of interest with any of the following:
(1) The insurer that is the subject of the
external review;
(2) the insured
whose treatment is the subject of the external review or the insured's
authorized representative;
(3) any
officer, director, or management employee of the insurer that is the subject of
the external review;
(4) the
health care provider, the health care provider's medical group, or the
independent practice association recommending the health care service or
treatment that is the subject of the external review;
(5) the facility at which the recommended
health care service or treatment would be provided; or
(6) the developer or manufacturer of the
principal drug, device, procedure, or other therapy being recommended for the
insured whose treatment is the subject of the external review.
This regulation shall take effect on and after January 1, 2000.
Notes
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.